Application segmentation of the erythrulose market is dominated by three functional domains: cosmetics & personal care, pharmaceuticals, and research & development. The cosmetics & personal care segment accounts for roughly 65 % of total revenue, driven by the compound’s role as a self‑tanning agent that offers a gradual, low‑irritation colour development. Within this domain, product lines such as spray tans, lotions, and professional salon formulations contribute the bulk of demand. The pharmaceuticals segment, representing about 20 % of the market, leverages erythrulose’s low‑glycemic properties for topical formulations aimed at wound‑healing and diabetic skin care, where its mild oxidative activity supports cellular regeneration. The remaining 15 % is allocated to research & development activities, including academic studies and contract manufacturing services that explore novel delivery systems, synergistic blends, and regulatory pathways. This application‑centric breakdown underpins the overall market size, as each segment’s growth trajectory directly influences production volumes, pricing power, and investment allocation across the supply chain. The distribution is reflected in the accompanying pie‑chart, which visualises the relative weight of each application in the current market landscape.
